Volume 11 - Issue 10 - October, 2003
06/19/2008
S.M.A.R.T.® Stent Receives FDA Approval for Treatment of Iliac Artery Disease
Cordis Endovascular has received U.S. Food and Drug Administration (FDA) approval for primary stenting of the iliac arteries with the S.M.A.R.T. ® Nitinol Stent...
S.M.A.R.T.® Stent Receives FDA Approval for Treatment of Iliac Artery Disease
Cordis Endovascular has received U.S. Food and Drug Administration (FDA) approval for primary stenting of the iliac arteries with the S.M.A.R.T. ® Nitinol Stent...
S.M.A.R.T.® Stent Receives FDA...
06/19/2008
Cath Lab Digest
Feature
06/19/2008
S.M.A.R.T.® Stent Receives FDA Approval for Treatment of Iliac Artery Disease
Cordis Endovascular has received U.S. Food and Drug Administration (FDA) approval for primary stenting of the iliac arteries with the S.M.A.R.T. ® Nitinol Stent...
S.M.A.R.T.® Stent Receives FDA Approval for Treatment of Iliac Artery Disease
Cordis Endovascular has received U.S. Food and Drug Administration (FDA) approval for primary stenting of the iliac arteries with the S.M.A.R.T. ® Nitinol Stent...
S.M.A.R.T.® Stent Receives FDA...
06/19/2008
Cath Lab Digest
Feature
06/19/2008
Held September 15-19, 2003, in Washington, D.C.
Held September 15-19, 2003, in Washin...
Boston Scientific Delivers Drug Stent Trial Data
Physicians had expected Boston Scientific’s Taxus IV trial to show a restenosis rate of 9% to perhaps as high as 11% in patients receiving the company's drug-eluting stent. Instead, the...
Boston Scientific Delivers Drug Stent Trial Data
Physicians had expected Boston Scientific’s Taxus IV trial to show a restenosis rate of 9% to perhaps as high as 11% in patients receiving the company's drug-eluting stent. Instead, the...
Boston Scientific Delivers Drug...
06/19/2008
Cath Lab Digest
06/19/2008
Held September 15-19, 2003, in Washington, D.C.
Held September 15-19, 2003, in Washin...
Boston Scientific Delivers Drug Stent Trial Data
Physicians had expected Boston Scientific’s Taxus IV trial to show a restenosis rate of 9% to perhaps as high as 11% in patients receiving the company's drug-eluting stent. Instead, the...
Boston Scientific Delivers Drug Stent Trial Data
Physicians had expected Boston Scientific’s Taxus IV trial to show a restenosis rate of 9% to perhaps as high as 11% in patients receiving the company's drug-eluting stent. Instead, the...
Boston Scientific Delivers Drug...
06/19/2008
Cath Lab Digest
06/19/2008
She then returned to Thailand, and after establishing the cardiac catheterization laboratory, CCU and cardiology training program at Vajira hospital, she became a pioneer in coronary angiography and interventional cardiology with very low...
She then returned to Thailand, and after establishing the cardiac catheterization laboratory, CCU and cardiology training program at Vajira hospital, she became a pioneer in coronary angiography and interventional cardiology with very low...
She then returned to Thailand,...
06/19/2008
Cath Lab Digest
06/19/2008
Tracy Simpson, President, SICP
Tracy Simpson, President, SICP
-Dear SICP members, colleagues, and friends,
As the lazy days of summer roll into cool fall evenings I wanted to take a few moments to touch base with you. It has been six months since the SICP leadership changed and I wanted to extend a...
-Dear SICP members, colleagues, and friends,
As the lazy days of summer roll into cool fall evenings I wanted to take a few moments to touch base with you. It has been six months since the SICP leadership changed and I wanted to extend a...
-Dear SICP members, colleagues,...
06/19/2008
Cath Lab Digest
Feature
06/19/2008
Tracy Simpson, President, SICP
Tracy Simpson, President, SICP
-Dear SICP members, colleagues, and friends,
As the lazy days of summer roll into cool fall evenings I wanted to take a few moments to touch base with you. It has been six months since the SICP leadership changed and I wanted to extend a...
-Dear SICP members, colleagues, and friends,
As the lazy days of summer roll into cool fall evenings I wanted to take a few moments to touch base with you. It has been six months since the SICP leadership changed and I wanted to extend a...
-Dear SICP members, colleagues,...
06/19/2008
Cath Lab Digest
06/19/2008
John McB. Hodgson, MD, FSCAI
Heart and Vascular Center
MetroHealth Medical Center
Cleveland, Ohio
President, Society for Cardiac Angiography & Interventions
John McB. Hodgson, MD, FSCAI
Heart an...
Mel was playing racquetball when he first experienced the dull substernal pressure. When it persisted, he decided to call off the game and head home. Debbie knew something was wrong the minute he came in. While Mel waited on the couch she...
Mel was playing racquetball when he first experienced the dull substernal pressure. When it persisted, he decided to call off the game and head home. Debbie knew something was wrong the minute he came in. While Mel waited on the couch she...
Mel was playing racquetball when...
06/19/2008
Cath Lab Digest
Feature
06/19/2008
ASOCC is in Orlando!
Join your fellow cardiac catheterization professionals at the educational event of the year!
HMP Communications and Cath Lab Digest are pleased to announce:
The 2004 Cath Lab Digest Third Annual Symposium on...
ASOCC is in Orlando!
Join your fellow cardiac catheterization professionals at the educational event of the year!
HMP Communications and Cath Lab Digest are pleased to announce:
The 2004 Cath Lab Digest Third Annual Symposium on...
ASOCC is in Orlando!
Join your...
06/19/2008
Cath Lab Digest
06/19/2008
ASOCC is in Orlando!
Join your fellow cardiac catheterization professionals at the educational event of the year!
HMP Communications and Cath Lab Digest are pleased to announce:
The 2004 Cath Lab Digest Third Annual Symposium on...
ASOCC is in Orlando!
Join your fellow cardiac catheterization professionals at the educational event of the year!
HMP Communications and Cath Lab Digest are pleased to announce:
The 2004 Cath Lab Digest Third Annual Symposium on...
ASOCC is in Orlando!
Join your...
06/19/2008
Cath Lab Digest
